Blood Test for Lung Cancer in the Works
Title: Blood Test for Lung Cancer in the Works Category: Health News Created: 1/15/2010 10:51:00 AM Last Editorial Review: 1/15/2010 10:51:40 AM
Read more on MedicineNet.com
Blood Test for Lung Cancer in the Works
WellPoint routinely targets breast cancer patients
WellPoint routinely targets breast cancer patients
Shortly after they were diagnosed with breast cancer, each of the women learned that her health insurance had been canceled. There was Yenny Hsu, who lived and worked in Los Angeles. And there was Patricia Reilling, a successful art gallery owner and interior designer from Louisville, Kentucky.
Read more on Reuters via Yahoo! News
Related posts
New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors
Primitive neuroectodermal tumors (PNETs) arise from undifferentiated brain cells and are the most frequent malignant brain tumors in children. There are different forms of PNETs and, while scientists have made progress in characterizing the genetic abnormalities associated with some PNET subtypes, the highly aggressive cerebral tumors known as CNS-PNETs have been difficult to characterize as they represent a relatively uncommon group of tumors with ill-defined diagnostic features.
“Lack of insight into the molecular pathogenesis of CNS-PNET is a major obstacle towards development of disease-specific models and treatments for these frequently fatal malignancies,” explains senior study author, Dr. Annie Huang from the Hospital for Sick Children in Ontario, Canada. To comprehensively define relevant genetic alterations associated with CNS-PNET, Dr. Huang established international collaborations with colleagues from pediatric oncology centers in Asia, Europe and the United States to complete a sophisticated high resolution genomic screen of a large collection of primary tumors.
» Read more: New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors